Attached files
file | filename |
---|---|
8-K - CURRENT REPORT - VistaGen Therapeutics, Inc. | vtgn8k_09152017.htm |
Exhibit
3.1
CERTIFICATE OF AMENDMENT
TO THE
RESTATED AND AMENDED
ARTICLES OF INCORPORATION
OF
VISTAGEN THERAPEUTICS, INC.
VistaGen
Therapeutics, Inc., a Nevada corporation (the "Corporation"), does hereby certify that:
FIRST: This
Certificate of Amendment amends the provisions of the Corporation's
Restated and Amended Articles of Incorporation (the
"Articles
of Incorporation").
SECOND: The
terms and provisions of this Certificate of Amendment have been
duly adopted in accordance with Section 78.380 of the Nevada
Revised Statutes and shall become effective immediately upon filing
this Certificate of Amendment.
THIRD: The
first paragraph of Article V of the Articles of Incorporation is
hereby amended in its entirety and replaced with the
following:
“This
corporation is authorized to issue two classes of capital stock, to
be designated “Common Stock” and “Preferred
Stock.” The total number of shares of Common Stock
which this corporation is authorized to issue is One Hundred
Million (100,000,000), each having a par value of $0.001. The total
number of shares of Preferred Stock which this corporation is
authorized to issue is Ten Million (10,000,000), each having a par
value of $0.001. The holders of the Common Stock shall
have one (1) vote per share on each matter submitted to a vote of
stockholders. The capital stock of this corporation,
after the amount of the subscription price has been paid in, shall
never be assessable, or assessed to pay debts of this
corporation.”
IN WITNESS
WHEREOF, the Corporation has caused this Certificate of Amendment
to be signed by its officers thereunto duly authorized this 15th
day of September, 2017.
By:
/s/ Shawn
K. Singh
Name: Shawn
K. Singh
Title:
Chief Executive Officer